DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Australia
  • /
  • Healthcare
Author Program NEWCreate Narrative
SHL logo

Sonic Healthcare Limited Stock Price

ASX:SHL Community·AU$9.6b Market Cap
  • 5 Narratives written by author
  • 4 Comments on narratives written by author
  • 159 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

SHL Share Price Performance

AU$0
-22.70 (-100.00%)
​
AU$22.51
Fair Value
AU$0
-22.70 (-100.00%)
​
Price AU$0
Thu, 3 Sep 26
Fair ValueAU$22.51
Share Pricen/a

SHL Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value AU$22.51 14.0% undervalued intrinsic discount

Digital Pathology And Global Expansion Will Define Healthcare

1users have liked this narrative
4users have commented on this narrative
74users have followed this narrative
DA
danmad's
Fair Value
·
Fair Value AU$27 28.3% undervalued intrinsic discount

Sonic Healthcare is poised for large upside as margins recover

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
CH
Choppy's
Fair Value
·
Fair Value AU$30 35.4% undervalued intrinsic discount

Sonic Healthcare Is Priced for Yesterday. Its AI Is Built for Tomorrow.

2users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
SHL logo
Sonic Healthcare
28.3% undervalued intrinsic discount

Sonic Healthcare is poised for large upside as margins recover

View narrative
DA
Emerging Author
danmad
Published 22 Jul
Read Narrative
SHL logo
Sonic Healthcare
35.4% undervalued intrinsic discount

Sonic Healthcare Is Priced for Yesterday. Its AI Is Built for Tomorrow.

View narrative
CH
Choppy
Published 21 Apr
Read Narrative
SHL logo
Sonic Healthcare
14.0% undervalued intrinsic discount

Digital Pathology And Global Expansion Will Define Healthcare

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 3 Sep
Read Narrative
SHL logo
Sonic Healthcare
33.4% undervalued intrinsic discount

Radiology And Genetics Demand Will Transform This Diagnostics Consolidator Over The Next Decade

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 30 Jul
Read Narrative
SHL logo
Sonic Healthcare
7.6% overvalued intrinsic discount

Genetics And Radiology Services Will Support Steady Margins And Fairly Priced Prospects

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 2 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

DA
SHL logo

Sonic Healthcare is poised for large upside as margins recover

Fair Value: AU$27 28.3% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
CH
SHL logo

Sonic Healthcare Is Priced for Yesterday. Its AI Is Built for Tomorrow.

Fair Value: AU$30 35.4% undervalued intrinsic discount
9 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
SHL logo

SHL: Slightly Higher Discount Rate Will Still Support Positive Long-Term Outlook

Fair Value: AU$22.51 14.0% undervalued intrinsic discount
74 fair values setusers have set this as their fair value
4 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued established dividend payer.

0 Risks
4 Rewards
View Full Analysis

Sonic Healthcare Limited Key Details

AU$10.9b

Revenue

AU$7.3b

Cost of Revenue

AU$3.6b

Gross Profit

AU$3.0b

Other Expenses

AU$608.3m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
1.23
32.99%
5.60%
43.8%
View Full Analysis

About SHL

Founded
1934
Employees
45000
CEO
James Newcombe
WebsiteView website
www.sonichealthcare.com

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Recent SHL News & Updates

User avatar
Narrative Update • Sep 03

SHL: Slightly Higher Discount Rate Will Still Support Positive Long-Term Outlook

Analysts have trimmed their fair value estimate for Sonic Healthcare from about A$23.36 to A$22.51 as they factor in updated assumptions for discount rates, revenue growth, profit margins and future P/E multiples. What’s in the News for Sonic Healthcare No recent Sonic Healthcare specific news items were identified in the provided sources as of 1 Sep 2026.

Recent updates

No updates

Sonic Healthcare Limited Competitors

SIG logo

Sigma Healthcare

Symbol: ASX:SIG
Market cap: AU$30.4b
PME logo

Pro Medicus

Symbol: ASX:PME
Market cap: AU$17.4b
RHC logo

Ramsay Health Care

Symbol: ASX:RHC
Market cap: AU$12.4b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide